CAS: 39929-79-8; 7H-Pyrrolo[2,3-D]Pyrimidine-2,4-Diol

该化合物是一种环状的七环有机化合物,其二,四个位置有引信的火花和火烈林环系统,有氢氧化物替代体,该结构在药用化学方面,特别是在研制核分子类比和酶抑制剂方面,具有多种功能,其硬性双环形框架和功能组能够与生物目标进行选择性互动,对药物研究很有价值.复合物展因其具有模仿纯碱基的能力,有可能成为抗病毒或抗癌剂的前体.可精确合成应用的高纯度,确保药物发现和生物化学研究的再生性.

结构式图片

欧盟法规

REACH注册C&L通报REACH预注册

上下游产品

4-Amino-2,6-dihydroxy-5-(2,2-diethoxy-ethyl)-pyrimidin 2-chloroethanal 4-Amino-2,6-dihydroxypyrimidine 6-amino-2,4-dihydroxypyrimidine 2,4-dichloro-7H-pyrrolo[2,3-d]pyrimidine 2-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-ol 2-((2-chloro-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile 2-((2-chloro-7-methyl-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)methyl)benzonitrile

合成工艺路线路线简述

    2,4-二甲氧基-7H-吡咯并[2,3-D]嘧啶置于盐酸体系中,用 1,4-二氧六环 用作溶剂,化学反应生成2,4-二羟基吡咯[2,3-D]嘧啶
    参考文献:Ara-7-Deazaxanthosine-具有稳定n-糖基键的黄嘌呤核苷
    标题:Ara-7-Deazaxanthosine-具有稳定n-糖基键的黄嘌呤核苷
    摘要:Ara-7-Deazaxanthosine(2)的制备是通过相转移糖基化的2,4-二甲氧基-7 ħ吡咯并[2,3-D ]嘧啶(图5B与halogenose)6.用三氯化硼除去优选在糖基化反应中形成的β-端基异构体8的苄基保护基,并用酸分离出2,4-二甲氧基.与黄嘌呤(1A)相反,7-脱氮嘌呤核苷2具有在酸水解时稳定的n-糖基键.通过比较嘌呤核苷与2的动力学参数描述了质子催化水解的反应机理,也解释了吡咯并[2,3-D ]嘧啶核苷2的稳定性.
    Doi:10.1002/jlac.198419840210

    海关参考信息

    专利信息


    专利号:US-6639059-B1
    优先权日:1999-03-24
    标 题 :Synthesis of [2.2.1]bicyclo nucleosides
    发明人:KOCHKINE ALEXEI; FENSHOLDT JEF; PFUNDHELLER HENRIK M
    权利人:EXIQON AS
    摘要:A synthesis of [2.2.1]bicyclo nucleosides which is shorter and provides higher overall yields proceeds via the key intermediate of the general formula III, wherein R4 and R5 are, for instance, sulfonates and R7 is, for instance, a halogen or an acetate. From compounds of the general formula II, such as 3-O-aryl-4-C-hydroxymethyl-1,2-O-isopropylidene-alpha-D-ribofuranose, intermediates of the general formula III are suitable for coupling with silylated nucleobases. Upon one-pot base-induced ring-closure and desulfonation of the formed [2.2.1]bicyclo nucleoside, a short route to each the LNA (Locked Nucleic Acid) derivatives of adenosine, cytosine, uridine, thymidine and guanidine is demonstrated. The use of the 5'-sulfonated ring-closed intermediate also allows for synthesis of 5'-amino- and thio-LNAs.

    专利号:US-6734291-B2
    优先权日:1999-03-24
    标题:Synthesis of [2.2.1]bicyclo nucleosides
    发明人:KOCHKINE ALEXEI; FENSHOLDT JEF; PFUNDHELLER HENRIK M
    权利人:EXIQON AS
    摘要:A synthesis of [2.2.1]bicyclo nucleosides which is shorter and provides higher overall yields proceeds via the key intermediate of the general formula III, wherein R4 and R5 are, for instance, sulfonates and R7 is, for instance, a halogen or an acetate. From compounds of the general formula II, such as 3-O-aryl-4-C-hydroxymethyl-1,2-O-isopropylidene-alpha-D-ribofuranose, intermediates of the general formula III are suitable for coupling with silylated nucleobases. Upon one-pot base-induced ring-closure and desulfonation of the formed [2.2.1]bicyclo nucleoside, a short route to each the LNA (Locked Nucleic Acid) derivatives of adenosine, cytosine, uridine, thymidine and guanidine is demonstrated. The use of the 5'-sulfonated ring-closed intermediate also allows for synthesis of 5'-amino- and thio-LNAs

    专利号:EP-1501848-B1
    优先权日:2002-05-08
    标 题 :Synthesis of locked nucleic acid derivatives
    发明人:SORENSEN MADS DETLEF; WENGEL JESPER; KOCH TROELS; CHRISTENSEN SIGNE M; ROSENBOHM CHRISTOPH; PEDERSEN DANIEL SEJER
    权利人:SANTARIS PHARMA AS
    摘要:The invention relates to a novel strategy for the synthesis of Locked Nucleic Acid derivatives, such as alpha-L-oxy-LNA, amino-LNA, alpha-L-amino-LNA, thio-LNA, alpha-L-thio-LNA, seleno-LNA and methylene LNA, which provides scalable high yielding reactions utilising intermediates that also can produce other LNA analogues such as oxy-LNA. Also, the compounds of the formula X are important intermediates that may be reacted with varieties of nucleophiles leading to a wide variety of LNA analogues. (Formula I)

    专利号:US-7915201-B2
    优先权日:2003-03-20
    标 题:Ligational encoding of small molecules
    发明人:FRANCH THOMAS; JACOBSEN SOEREN NYBOE; RASMUSSEN TORBEN RAVN; NEVE SOEREN; PEDERSEN HENRIK; GOULIAEV ALEX HAAHR
    权利人:NUEVOLUTION AS
    摘要:The invention relates to a method for synthesising a bifunctional complex comprising an encoded molecule and an identifier polynucleotide identifying the chemical entities having participated in the synthesis of the encoded molecule, said method comprising the steps of i) providing a) at least one template comprising one or more codons capable of hybridising to an anti-codon, wherein said template is optionally associated with one or more chemical entities, and b) a plurality of building blocks each comprising an anti-codon associated with one or more chemical entities, and ii) hybridising the anti-codon of one or more of the provided building blocks to the template, iii) covalently linking said anti-codons and/or linking the at least one template with the anti-codon of at least one building block, thereby generating an identifier polynucleotide capable of identifying chemical entities having participated in the synthesis of the encoded molecule, iv) separating the template from one or more of the anti-codons hybridised thereto, thereby generating an at least partly single stranded identifier polynucleotide associated with a plurality of chemical entities, v) generating a bifunctional complex comprising an encoded molecule and an identifier polynucleotide identifying the chemical entities having participated in the synthesis of the encoded molecule, wherein said encoded molecule is generated by reacting at least two of said plurality of chemical entities associated with the identifier polynucleotide, and wherein said at least two chemical entities are provided by separate building blocks.

    专利号:US-8309716-B2
    优先权日:2005-07-29
    标题 :Pyrrolo[2,3-d]pyrimidine derivatives: their intermediates and synthesis
    发明人:RUGGERI SALLY GUT; HAWKINS JOEL M; MAKOWSKI TERESA M; RUTHERFORD JENNIFER L; URBAN FRANK J
    权利人:RUGGERI SALLY GUT; HAWKINS JOEL M; MAKOWSKI TERESA M; RUTHERFORD JENNIFER L; URBAN FRANK J; PFIZER
    摘要:This invention relates to methods and intermediates useful for the synthesis of pyrrolo[2,3-d]pyrimidine compounds. Specifically novel synthetic methods and intermediates for the synthesis of 3-{(3R,4R)-4-methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino}-piperidin-1-yl)-3-oxo-propionitrile and its corresponding citrate salt are disclosed.

    专利号:US-10730906-B2
    优先权日:2002-08-01
    标题:Multi-step synthesis of templated molecules
    发明人:PEDERSEN HENRIK
    权利人:PEDERSEN HENRIK; NUEVOLUTIONS AS
    摘要:Disclosed is a method for the manufacture of a library of complexes. The complexes comprise templated molecules attached to the template which directed the synthesis thereof. The templated molecules are produced in a step-by-step fashion which provides for a high local concentration of reactive groups involved in the formation of connections between the individual components of the template molecule.
    南京新斯特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nstbio.com
    企业联系电话:025-85331029,18915981017👤
    📞南京新斯特生物科技有限公司 ⚠️参考联系方式
    联系人:杨女士
    电话:025-85331029,18915981017
    手机:18915981017
    传真:025-85331829
    邮箱:sales@nstbio.com
    通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    邮编: 210010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    阜新清稷升科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.qjsfb.com
    企业联系电话:陈佳|运营副总 13588048971👤
    📞阜新清稷升科技有限公司 ⚠️参考联系方式
    联系人:陈佳|运营副总
    电话:陈佳|运营副总 13588048971
    手机:13588048971
    传真:0418-8189431
    邮箱:sales@bomanbiochem.com
    通信地址: 阜新市阜蒙县氟化工园区
    邮编: 123000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:阜新市阜蒙县氟化工园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    安庆博曼生物技术有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.bomanbiochem.com
    企业联系电话:0556-5203536👤
    📞安庆博曼生物技术有限公司 ⚠️参考联系方式
    联系人:陈 佳(总经理) 何雪垠(技术总监)
    电话:0556-5203536
    手机:13588048971;18955636051/13365798276
    传真:0556-5203536
    邮箱:sales@bomanbiochem.com;chen@bomanbiochem.com
    通信地址: 安徽省安庆市高新区皇冠路8号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:安徽省安庆市高新区皇冠路8号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    济南合诚医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.pharmsyn.com
    电话: 0086-531-89128893 88927098👤
    📞济南合诚医药科技有限公司 ⚠️参考联系方式

    销售电话:0086-531-89128893 88927098
    邮箱:QYL1970@VIP.163.COM
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/np050221o
    摘要:Nasib A, Musharraf SG, Hussain S, Khan S, Anjum S, Ali S, Atta-ur-Rahman, Choudhary MI. Biotransformation of (−)-Ambrox by Cell Suspension Cultures of Actinidia deliciosa. J. Nat. Prod. 2006 Jun 01;69(6):957–9. doi: 10.1021/np050221o.
    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2014).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知